FDA DEVICE FACTS
The Circadia C300 System (C300)
Circadia Health, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Circadia C300 System is intended for the measurement of respiratory rate and heart rate, including spot measurement. The system is indicated for adult patients in clinical settings, such as skilled nursing and long-term care facilities. The system is not indicated for active patient monitoring, and does not provide alarms for timely response in acute life-threatening situations. The system is not intended to monitor heart rate in patients with arrhythmias. The system is intended to be used by healthcare professionals (HCPs) and data are intended to be reviewed by HCPs to inform patient care. The system also monitors patient motion, and patient presence or absence near the device (exits).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。